Finzati - Logo
SXTC logo

China SXT Pharmaceuticals, Inc.

SXTCDrug Manufacturers - Specialty & Generic
$2.23
+0.03 (+1.36%)
Current price
EarningsLatest report: Mar 31, 2025
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$5.45M
Growth
-51.6%
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.06Healthy liquidity · 3.54Negative growth trendWeak profitability
Financial data as of: Mar 31, 2025, 12:00 AM UTCLast earnings update: Mar 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$2.23
Change1.36%
Shares Out2.44M
Market Cap$5.45M
Enterprise Value$-14.67M
Beta1.89
P/E-1.65
P/S3.13
P/B0.27
P/FCF-2.32
EV/Sales-8.42
EV/EBITDA5.64

Investment DNA

How strong this company looks for long-term investors

31
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
21/100
Why this score
Manageable debt level · 0.06Healthy liquidity · 3.54Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 1/4/2019
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 0.27
Debt / Equity i: 0.06
Operating Margin: -153.97%
Net Margin: -189.77%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.06
Current Ratio: 3.54
Quick Ratio: 3.40
Status: Good

Insider Transactions

Recent executive and insider activity

Simon Lim Sze Beng
Transaction: 01/20/2025
OTHER
Change
0
Price
Not reported
Filing
04/27/2026
Type
OTHER
Chee Yong Lip
Transaction: 01/20/2025
OTHER
Change
0
Price
Not reported
Filing
04/27/2026
Type
OTHER
Liu Tong Tony
Transaction: 05/10/2022
OTHER
Change
0
Price
Not reported
Filing
04/27/2026
Type
OTHER